Presentation TCT 2019 TCT 71: Impact of Intravascular Ultrasound Guidance on Long-Term (10-Year) Mortality and Adverse Cardiovascular Events in Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease Presenter: Do-Yoon Kang September 25, 2019
Presentation TCT 2019 TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial Presenter: Run-Lin Gao September 25, 2019
Presentation TCT 2019 Case 5 (From Malaysia): Hybrid Approach in Diffuse Coronary Artery Disease Presenter: Kenneth Chin September 25, 2019
Presentation TCT 2019 TCT 26: Predictors of Bailout Rotational Atherectomy in Patients With Complex Calcified Coronary Artery Disease: A Pooled Analysis From the Randomized ROTAXUS and PREPARE-CALC Trials Presenter: Mohamed Abdel-Wahab September 25, 2019
News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019
News Daily News CMR May Help Evaluate Nonculprit Lesions in STEMI Patients Todd Neale September 19, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
News Conference News ESC 2019 TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization L.A. McKeown September 09, 2019
News Conference News ESC 2019 Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART Yael L. Maxwell September 04, 2019
News Conference News ESC 2019 CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients Shelley Wood September 03, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
Presentation ESC 2019 THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes Presenter: Deepak Bhatt September 01, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Conference News ESC 2019 COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter Yael L. Maxwell September 01, 2019
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Daily News Learning Curve for New CTO Operators: Some Reassurances, Some Caveats L.A. McKeown August 26, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019